MEDICAL UPDATE: European-Australian Collaborative Study Published

MEDICAL UPDATE: European-Australian Collaborative Study Published

Being Alive Newsletter; Beling Alive/Los Angeles - September 93
Mark Katz MD and reported by Jim Stoecker

Exactly one year after releasing results of the study in Amsterdam, the publication of the European-Australian Collaborative Study has finally occurred. This study looked at the effect of early antiviral intervention and will require further examination to integrate the results with those of the Concorde study and ACTG019. The study indicated the efficacy of 1000 mg daily of AZT in slowing progression of symptoms and new diagnoses of AIDS among subjects in the CD4 400-800 range. All current evidence seems to indicate that the higher the CD4 count when starting AZT, the longer the efficacy of the antiviral.
930900
BA930903

AEGiS is made possible through unrestricted grants from Roxane Laboratories, the National Library of Medicine, and donations from users like you. Always watch for outdated information. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1993 - Beings Alive. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. Being Alive, 621 N. San Vicente Blvd., West Hollywood, CA 90069, Tel - 310.289.2551; FAX - 310.289.9866; Email: BeiAlive@aol.com http://www.beingalivela.org/

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1993. AEGIS.